Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

AGENTIX CORP. (AGTX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

AGENTIX CORP. (AGTX), most recent 12 months reported: net loss $417.49K. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Senti Biosciences Holdings, Inc. · Creative Medical Technology Holdings, Inc. · Acumen Pharmaceuticals, Inc. · Abpro Holdings, Inc. · Allogene Therapeutics, Inc. · Adaptin Bio, Inc. · ARMATA PHARMACEUTICALS, INC. · Artiva Biotherapeutics, Inc.

Stock screener

Watchlist